Cerium oxide nanoparticles protect against Aβ-induced mitochondrial fragmentation and neuronal cell death

Cell Death and Differentiation

Volumn 21, Issue 10, 2014, Pages 1622-1632

  Dowding, J M ^a   Song, W ^a   Bossy, K ^a   Karakoti, A ^b   Kumar, A ^c   Kim, A ^d   Bossy, B ^a   Seal, S ^c   Ellisman, M H ^d   Perkins, G ^d   Self, W T ^a   Bossy Wetzel, E ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; CERIC OXIDE; CERIUM; DRP1 PROTEIN, RAT; DYNAMIN; METAL NANOPARTICLE; PEROXYNITROUS ACID; REACTIVE NITROGEN SPECIES;

ANIMAL; APOPTOSIS; CHEMISTRY; DRUG EFFECTS; METABOLISM; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MITOPHAGY; NERVE CELL; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PATHOLOGY; PHOSPHORYLATION; RAT; SPRAGUE DAWLEY RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CERIUM; DYNAMINS; METAL NANOPARTICLES; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; MITOCHONDRIAL MEMBRANES; NEURODEGENERATIVE DISEASES; NEURONS; OXIDATIVE STRESS; PEROXYNITROUS ACID; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE NITROGEN SPECIES;

EID: 84928997316     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.72     Document Type: Article

References (63)

1. Knott AB, Bossy-Wetzel E. Nitric oxide in health and disease of the nervous system. Antioxid Redox Signal 2009; 11: 541-554.
2. Beal MF. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 2002; 32: 797-803.
3. Good PF, Werner P, Hsu A, Olanow CW, Perl DP. Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol 1996; 149: 21.
4. Guix FX, Ill-Raga G, Bravo R, Nakaya T, de Fabritiis G, Coma M et al. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation. Brain 2009; 132(Pt 5): 1335-1345.
5. Guix FX, Wahle T, Vennekens K, Snellinx A, Chavez-Gutierrez L, Ill-Raga G et al. Modification of gamma-secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer's disease. EMBO Mol Med 2012; 4: 660-673.
6. Kummer MP, Hermes M, Delekarte A, Hammerschmidt T, Kumar S, Terwel D et al. Nitration of tyrosine 10 critically enhances amyloid b aggregation and plaque formation. Neuron 2011; 71: 833-844.
7. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G. Widespread peroxynitritemediated damage in Alzheimer's disease. J Neurosci 1997; 17: 2653-2657.
8. Ghatan S, Larner S, Kinoshita Y, Hetman M, Patel L, Xia Z et al. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J Cell Biol 2000; 150: 335-347.
9. Stamler JS, Lamas S, Fang FC. Nitrosylation. the prototypic redox-based signaling mechanism. Cell 2001; 106: 675-683.
10. Aizenman E, Stout AK, Hartnett KA, Dineley KE, McLaughlin B, Reynolds IJ. Induction of neuronal apoptosis by thiol oxidation: putative role of intracellular zinc release. J Neurochem 2000; 75: 1878-1888.
11. Bossy-Wetzel E, Talantova MV, Lee WD, Scholzke MN, Harrop A, Mathews E et al. Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron 2004; 41: 351-365.
12. Cuajungco MP, Lees GJ. Nitric oxide generators produce accumulation of chelatable zinc in hippocampal neuronal perikarya. Brain Res 1998; 799: 118-129.
13. Yamamoto T, Maruyama W, Kato Y, Yi H, Shamoto-Nagai M, Tanaka M et al. Selective nitration of mitochondrial complex I by peroxynitrite: involvement in mitochondria dysfunction and cell death of dopaminergic SH-SY5Y cells. J Neural Transm 2002; 109: 1-13.
14. Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 2008; 9: 505-518.
15. Swerdlow RH, Burns JM, Khan SM. The Alzheimer's disease mitochondrial cascade hypothesis. J Alzheimers Dis 2010; 20(Suppl 2): S265-S279.
16. Barsoum MJ, Yuan H, Gerencser AA, Liot G, Kushnareva Y, Graber S et al. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 2006; 25: 3900-3911.
17. Gan X, Huang S, Wu L, Wang Y, Hu G, Li G et al. Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell. Biochim Biophys Acta 2014; 1842: 220-231.
18. Manczak M, Calkins MJ, Reddy PH. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Hum Mol Genet 2011; 20: 2495-2509.
19. Smirnova E, Griparic L, Shurland DL, van der Bliek AM. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell 2001; 12: 2245-2256.
20. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z et al. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 2009; 324: 102-105.
21. Bossy B, Petrilli A, Klinglmayr E, Chen J, Lutz-Meindl U, Knott AB et al. S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease. J Alzheimers Dis 2010; 20(Suppl 2): S513-S526.
22. Wang X, Su B, Lee HG, Li X, Perry G, Smith MA et al. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 2009; 29: 9090-9103.
23. Taguchi N, Ishihara N, Jofuku A, Oka T, Mihara K. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem 2007; 282: 11521-11529.
24. Strack S, Wilson TJ, Cribbs JT. Cyclin-dependent kinases regulate splice-specific targeting of dynamin-related protein 1 to microtubules. J Cell Biol 2013; 201: 1037-1051.
25. Crews L, Masliah E. Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum Mol Genet 2010; 19: R12-R20.
26. Murakami K, Murata N, Noda Y, Tahara S, Kaneko T, Kinoshita N et al. SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid beta protein oligomerization and memory loss in mouse model of Alzheimer disease. J Biol Chem 2011; 286: 44557-44568.
27. Richardson JS. Free radicals in the genesis of Alzheimer's Disease. Ann N Y Acad Sci 1993; 695: 73-76.
28. Esposito L, Raber J, Kekonius L, Yan F, Yu G-Q, Bien-Ly N et al. Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J Neurosci 2006; 26: 5167-5179.
29. Massaad CA, Washington TM, Pautler RG, Klann E. Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2009; 106: 13576-13581.
30. Esch F, Fabris S, Zhou L, Montini T, Africh C, Fornasiero P et al. Electron localization determines defect formation on ceria substrates. Science 2005; 309: 752-755.
31. Heckert EG, Karakoti AS, Seal S, Self WT. The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials 2008; 29: 2705-2709.
32. Korsvik C, Patil S, Seal S, Self WT. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem Commun 2007; 10: 1056-1058.
33. Pirmohamed T, Dowding JM, Singh S, Wasserman B, Heckert E, Karakoti AS et al. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem Commun (Camb) 2010; 46: 2736-2738.
34. Dowding JM, Dosani T, Kumar A, Seal S, Self WT. Cerium oxide nanoparticles scavenge nitric oxide radical (NO). Chem Commun (Camb) 2012; 48: 4896-4898.
35. Estevez AY, Pritchard S, Harper K, Aston JW, Lynch A, Lucky JJ et al. Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Radic Biol Med 2011; 51: 1155-1163.
36. Singh S, Kumar A, Karakoti A, Seal S, Self WT. Unveiling the mechanism of uptake and sub-cellular distribution of cerium oxide nanoparticles. Mol Biosyst 2010; 6: 1813-1820.
37. Karakoti AS, Munusamy P, Hostetler K, Kodali V, Kuchibhatla S, Orr G et al. Preparation and characterization challenges to understanding environmental and biological impacts of nanoparticles. Surf Interface Anal 2012; 44: 882-889.
38. Liot G, Bossy B, Lubitz S, Kushnareva Y, Sejbuk N, Bossy-Wetzel E. Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA-and ROS-dependent pathway. Cell Death Differ 2009; 16: 899-909.
39. Chaturvedi RK, Beal MF. Mitochondrial approaches for neuroprotection. Ann N Y Acad Sci 2008; 1147: 395-412.
40. Gilgun-Sherki Y, Melamed E, Offen D. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 2001; 40: 959-975.
41. Frei B. Efficacy of dietary antioxidants to prevent oxidative damage and inhibit chronic disease. J Nutr 2004; 134: 3196S-3198S.
42. Amin KA, Hassan MS, Awad el ST, Hashem KS. The protective effects of cerium oxide nanoparticles against hepatic oxidative damage induced by monocrotaline. Int J Nanomed 2011; 6: 143-149.
43. Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki E, Isobe C. Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Neurosci Lett 1999; 269: 52-54.
44. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87: 315-424.
45. Fuenzalida K, Quintanilla R, Ramos P, Piderit D, Fuentealba RA, Martinez G et al. Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. J Biol Chem 2007; 282: 37006-37015.
46. Shibuya A, Wada K, Nakajima A, Saeki M, Katayama K, Mayumi T et al. Nitration of PPARgamma inhibits ligand-dependent translocation into the nucleus in a macrophage-like cell line, RAW 264. FEBS Lett 2002; 525: 43-47.
47. Das M, Patil S, Bhargava N, Kang JF, Riedel LM, Seal S et al. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 2007; 28: 1918-1925.
48. Schubert D, Dargusch R, Raitano J, Chan SW. Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Commun 2006; 342: 86-91.
49. Chen J, Patil S, Seal S, McGinnis JF. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol 2006; 1: 142-150.
50. Zhou X, Wong LL, Karakoti AS, Seal S, McGinnis JF. Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse. PLoS One 2011; 6: e16733.
51. Niu J, Azfer A, Rogers LM, Wang X, Kolattukudy PE. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc Res 2007; 73: 549-559.
52. Arnold MC, Badireddy AR, Wiesner MR, Di Giulio RT, Meyer JN. Cerium oxide nanoparticles are more toxic than equimolar bulk cerium oxide in Caenorhabditis elegans. Arch Environ Contam Toxicol 2013; 65: 224-233.
53. Cheng G, Guo W, Han L, Chen E, Kong L, Wang L et al. Cerium oxide nanoparticles induce cytotoxicity in human hepatoma SMMC-7721 cells via oxidative stress and the activation of MAPK signaling pathways. Toxicol In Vitro 2013; 27: 1082-1088.
54. Kumari M, Singh SP, Chinde S, Rahman MF, Mahboob M, Grover P. Toxicity study of cerium oxide nanoparticles in human neuroblastoma cells. Int J Toxicol 2014; 33: 86-97.
55. Ristow M, Schmeisser S. Extending life span by increasing oxidative stress. Free Radic Biol Med 2011; 51: 327-336.
56. Heckman KL, DeCoteau W, Estevez A, Reed KJ, Costanzo W, Sanford D et al. Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain. ACS Nano 2013; 7: 10582-10596.
57. Kim CK, Kim T, Choi IY, Soh M, Kim D, Kim YJ et al. Ceria nanoparticles that can protect against ischemic stroke. Angew Chem Int Ed Engl 2012; 51: 11039-11043.
58. Yokel RA, Au TC, MacPhail R, Hardas SS, Butterfield DA, Sultana R et al. Distribution, elimination, and biopersistence to 90 days of a systemically introduced 30 nm ceriaengineered nanomaterial in rats. Toxicol Sci 2012; 127: 256-268.
59. Karakoti AS, Das S, Thevuthasan S, Seal S. PEGylated inorganic nanoparticles. Angew Chem Int Ed Engl 2011; 50: 1980-1994.
60. Song W, Bossy B, Martin OJ, Hicks A, Lubitz S, Knott AB et al. Assessing mitochondrial morphology and dynamics using fluorescence wide-field microscopy and 3D image processing. Methods 2008; 46: 295-303.
61. Patil S, Kuiry SC, Seal S, Vanfleet R. Synthesis of nanocrystalline ceria particles for high temperature oxidation resistant coating. J Nanopart Res 2002; 4: 433-438.
62. Burroughs P, Hamnett A, Orchard AF, Thornton G. Satellite structure in X-Ray photoelectron-spectra of some binary and mixed oxides of lanthanum and cerium. J Chem Soc Dalton Trans 1976; 17: 1686-1698.
63. Romeo M, Bak K, Elfallah J, Lenormand F, Hilaire L. Xps study of the reduction of cerium dioxide. Surf Interface Anal 1993; 20: 508-512.